DE CATERINA, Raffaele
 Distribuzione geografica
Continente #
NA - Nord America 9.669
EU - Europa 9.651
AS - Asia 4.106
Continente sconosciuto - Info sul continente non disponibili 30
AF - Africa 12
SA - Sud America 7
OC - Oceania 6
Totale 23.481
Nazione #
US - Stati Uniti d'America 9.634
UA - Ucraina 2.251
CN - Cina 2.047
IE - Irlanda 2.027
TR - Turchia 1.598
GB - Regno Unito 1.232
SE - Svezia 1.054
IT - Italia 996
FR - Francia 796
DE - Germania 640
FI - Finlandia 433
IN - India 172
SG - Singapore 128
VN - Vietnam 88
AT - Austria 75
BE - Belgio 40
RU - Federazione Russa 32
EU - Europa 28
IL - Israele 28
CA - Canada 25
IR - Iran 14
GR - Grecia 13
NL - Olanda 11
PL - Polonia 11
CZ - Repubblica Ceca 9
KR - Corea 9
MX - Messico 9
EG - Egitto 6
AU - Australia 5
CH - Svizzera 5
HK - Hong Kong 5
TN - Tunisia 5
DK - Danimarca 4
JP - Giappone 4
BG - Bulgaria 3
ES - Italia 3
HU - Ungheria 3
TH - Thailandia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BR - Brasile 2
CL - Cile 2
LB - Libano 2
MN - Mongolia 2
PE - Perù 2
PT - Portogallo 2
SI - Slovenia 2
AD - Andorra 1
AL - Albania 1
BO - Bolivia 1
EE - Estonia 1
GE - Georgia 1
ID - Indonesia 1
KZ - Kazakistan 1
LI - Liechtenstein 1
LU - Lussemburgo 1
ME - Montenegro 1
MT - Malta 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PK - Pakistan 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 23.481
Città #
Jacksonville 2.689
Dublin 2.012
Chandler 1.722
Princeton 1.035
Southend 1.020
Izmir 828
Nanjing 701
Cambridge 440
Wilmington 430
Altamura 411
Ashburn 323
Ann Arbor 267
Nanchang 260
Beijing 179
Boardman 177
Dearborn 162
Woodbridge 135
Chieti 127
Hebei 124
Kunming 122
Shenyang 121
Tianjin 105
Jiaxing 90
Dong Ket 88
Grevenbroich 75
Vienna 73
Singapore 72
Norwalk 65
Changsha 64
Hangzhou 60
Washington 55
Houston 54
Brussels 39
Orange 36
Lanzhou 35
New York 35
Los Angeles 34
Torino 31
Jinan 30
Falls Church 25
San Mateo 25
Augusta 23
Changchun 23
Seattle 23
Guangzhou 22
Leawood 21
Helsinki 20
Toronto 19
Taizhou 18
Pescara 17
Kocaeli 16
Campobasso 15
Teramo 14
Auburn Hills 13
Fairfield 13
Milan 13
Rome 13
Hefei 12
Ningbo 11
Shanghai 11
Serra 10
Zhengzhou 10
Ardabil 9
Cagliari 9
Bologna 8
Chicago 8
Haikou 7
Amsterdam 6
Andover 6
Cairo 6
Fort Worth 6
Fuzhou 6
Livorno 6
London 6
Secaucus 6
Brno 5
Chongqing 5
Cormeilles-en-Parisis 5
Kraków 5
L'aquila 5
Messina 5
Monmouth Junction 5
Mumbai 5
Redwood City 5
Tappahannock 5
Walnut 5
Beersheba 4
Clearwater 4
Frankfurt am Main 4
Hanover 4
Orsogna 4
San Vito Chietino 4
Sulmona 4
Acquaviva Picena 3
Atlanta 3
Bangalore 3
Bari 3
Bitritto 3
Budapest 3
Edinburgh 3
Totale 14.906
Nome #
Increased left atrial size in obese children and its association with insulin resistance: a pilot study 117
Accuratezza diagnostica della risonanza magnetica cardiaca nella misurazione anatomica e funzionale dell'area valvolare aortica: confronto con ecocardiografia transtoracica transesofagea 111
Response to "Pharmacodynamic Interaction Between Aspirin and Ibuprofen: A Plausible Mechanism of Aspirin Resistance" 105
Optical coherence tomography accurately identifies intermediate atherosclerotic lesions--an in vivo evaluation in the rabbit carotid artery 103
111In platelet scintigraphy for the noninvasive detection of carotid plaque thrombosis 102
Non-Invasive In Vivo Detection of Peripheral Limb Ischemia Improvement in the Rat After Adipose Tissue-Derived Stromal Cell Transplantation 102
Role and importance of ultrasound lung comets in acute cardiac care 101
Trimetazidine improves post-ischemic recovery by preserving endothelial nitric oxide synthase expression in isolated working rat hearts. 99
Verapamil reduces coronary endothelium damage and cardiomyocyte necrosis but not apoptosis after ischemia and reperfusion: ex vivo study in rat hearts. 99
Simvastatin attenuates expression of cytokine-inducible nitric-oxide synthase in embryonic cardiac myoblasts. 96
Optimal duration of antiplatelet therapy in recipients of coronary drug-eluting stents 95
Homocysteine induces VCAM-1 gene expression through NF-κB and NAD(P)H oxidase activation: Protective role of Mediterranean diet polyphenolic antioxidants 94
Diabetic macroangiopathy: Pathogenetic insights and novel therapeutic approaches with focus on high glucose-mediated vascular damage 94
Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial 94
Nitrates in cardiology: current role and areas of uncertainty 93
Bioenergetic and functional consequences of adipose tissue-derived stromal cell transplantation on the metabolism of ischemic muscle in a diabetic model. 93
Proteomic analysis of the secretome of adipose tissue-derived murine mesenchymal cells overexpressing telomerase and myocardin 91
Attivazione endoteliale e aterosclerosi 90
Intraoperative ischemia and long-term events after minimally invasive coronary surgery 89
Proteomic profiling of coronary thrombus in acute myocardial infarction 88
Age-dependent impairment of number and angiogenic potential of adipose tissue-derived progenitor cells 88
Transplantation of Mesenchymal Cells Improves Peripheral Limb Ischemia in Diabetic Rats 87
Intracardiac thrombi during warfarin anticoagulation - A case report and a brief literature review 86
Insulin enhances vascular adhesion molecule (VCAM-1) expression in human cultured endothelial cells through a pro-atherogenic p38MAP-kinase mediated pathway. 85
ST segment/heart rate hysteresis improves the diagnostic accuracy of ECG stress test for coronary artery disease in patients with left ventricular hypertrophy 85
SIMVASTATIN REDUCES REPERFUSION INJURY BY MODULATING NITRIC OXIDE SYNTHASE EXPRESSION:AN EX VIVO STUDY ISOLATED WORKING HEARTS 84
Erythropoietin protects myocardin-expressing cardiac stem cells against cytotoxicity of tumor necrosis factor-alpha 83
Genetic determinants of blood pressure responses to caffeine drinking 83
La gestione del rischio tromboembolico nei pazienti con fibrillazione atriale in Italia: Dati al follow-up del Registro Europeo PREFER in AF 83
Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events 82
Concentric remodeling detection by magnetocardiography in patients with recent onset arterial hypertension 81
Tumori cardiaci: Il ruolo della risonanza magnetica 81
Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF - HF substudy 81
Surgical bleeding after pre-operative unfractionated heparin and low molecular weight heparin for coronary bypass surgery 80
Early restenosis after drug-eluting stent implantation: A putative role for platelet activation 79
Awake systolic blood pressure variability correlates with target-organ damage in hypertensive subjects 79
Hospital admissions for orthostatic hypotension and syncope in later life: Insights from the Malmö Preventive Project 79
Hepatocyte growth factor/Met gene transfer in cardiac stem cells--potential for cardiac repair 79
Oxidative stress and cardiovascular risk: the role of vascular NAD(P)H oxidase and its genetic variants 79
Failure in evoking the trigeminal cardiac reflex by mandibular stretching in healthy volunteers 78
New Developments in Platelet Cyclic Nucleotide Signalling: Therapeutic Implications 78
Adipose tissue-derived stem cells: characterization and potential for cardiovascular repair 77
2012 focused update of the ESC Guidelines for the management of atrial fibrillation 77
Determinants of long-term clinical outcomes in patients with angina but without obstructive coronary artery disease: a systematic review and meta-analysis 77
Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs 76
Clinical case of significant "reverse remodeling" after cardiac resynchronization therapy 74
Late Thrombosis After Double Versus Single Drug-Eluting Stent in the Treatment of Coronary Bifurcations : a meta-analysis of randomized and observational Studies. 74
MR Angiography, MR Imaging and Proton MR Spectroscopy In-Vivo Assessment of Skeletal Muscle Ischemia in Diabetic Rats 74
Lung ultrasonography: a practical guide for cardiologists 74
Direct Oral Anticoagulants Halve Thromboembolic Events After Cardioversion of AF Compared With Warfarin 74
ACE-inhibitors versus angiotensin receptor blockers for prevention of events in cardiovascular patients without heart failure - A network meta-analysis 74
Thrombin-receptor antagonist vorapaxar in acute coronary syndromes 73
Isolated creatine kinase-MB rise with normal cardiac troponins: a strange occurrence with difficult interpretation 73
2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association 73
Cardiovascular morbidity and mortality related to orthostatic hypotension: A meta-analysis of prospective observational studies 73
Diagnosis and treatment of volume changes in acute heart failure- short practical guide [Diagnosi e trattamento delle alterazioni volemiche nello scompenso cardiaco acuto - breve guida pratica] 73
Thrombotic and hemorrhagic burden in women: Gender-related issues in the response to antithrombotic therapies 73
Quenching of intracellular ROS generation as a mechanism for oleate-induced reduction of endothelial activation and early atherogenesis 72
Anticoagulants in heart disease: current status and perspectives 72
A comparison of the diagnostic performance of the ST/HR hysteresis with cardiopulmonary stress testing parameters in detecting exercise-induced myocardial ischemia 72
Effect of chronic hypoxia on inducible nitric oxide synthase expression in rat myocardial tissue 72
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS 72
Psychotropic drugs and ventricular repolarisation: The effects on QT interval, T-peak to T-end interval and QT dispersion 72
The prominent role of p38 mitogen-activated protein kinase in insulin-mediated enhancement of VCAM-1 expression in endothelial cells. 71
Transcriptome-based identification of new anti-anti-inflammatory and vasodilating properties of the n-3 fatty acid docosahexaenoic acid in vascular endothelial cell under proinflammatory conditions 71
Relevance of new drug discovery to reduce NF-kB activation in cardiovascular disease 71
Rapid decline of collateral circulation increases susceptibility to myocardial ischemia: the trade-off of successful percutaneous recanalization of chronic total occlusions 70
Soluble adhesion molecules in healthy subjects: a dose-response study using n-3 fatty acids 70
Facilitated PCI: Rationale, current evidence, open questions and future directions 70
Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease 70
Cancer after intense and prolonged antiplatelet therapies – Fact or fiction? 70
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. nonselective COX-2 inhibitors 70
The left atrial appendage: from embryology to prevention of thromboembolism 70
Early Subclinical Atherosclerosis in Gestational Diabetes: The Predictive Role of Routine Biomarkers and Nutrigenetic Variants 70
Aspirin after acute myocardial infarction: a systematic approach to compare the hemostatic effects of three different doses. 69
Does optical coherence tomography identify arterial healing after stenting? An in vivo comparison with histology, in a rabbit carotid model 69
n-3 fatty acids in the treatment of diabetic patients: biological rationale and clinical data. 69
The AVERROES study 69
Short-term prevention of thromboembolic complications in patients with atrial fibrillation with aspirin plus clopidogrel: the Clopidogrel-Aspirin Atrial Fibrillation (CLAAF) pilot study 68
Genetic and nutritional interactions in cardiovascular disease 68
What is 'valvular' atrial fibrillation? A reappraisal 68
Chronic treatment with rosuvastatin modulates nitric oxide synthase expression and reduces ischemia-reperfusion injury in rat hearts. 68
Outcomes of anticoagulated patients with atrial fibrillation treated with or without antiplatelet therapy - A pooled analysis from the PREFER in AF and PREFER in AF PROLONGATON registries 68
Cardiovascular risk after hospitalisation for unexplained syncope and orthostatic hypotension 68
LOW-DOSE ASPIRIN IS A SELECTIVE INHIBITOR OF THROMBOXANE-RELATED PLATELET FUNCTION IN PATIENTS WITH MYOCARDIAL INFARCTION. 67
A double-blind randomized study of the anti-platelet effects of low-dose ASA and placebo in patients after myocardial infarction 67
Cytochromes CYP1A1 and CYP1B1: new pieces in the puzzle to understand the biomechanical paradigm of atherosclerosis 67
VEGF receptor switching in heart development and disease 67
Pre-hospital reperfusion therapy: a strategy to improve therapeutic outcome in patients with ST-elevation myocardial infarction 67
Ponatinib Induces Vascular Toxicity through the Notch-1 Signaling Pathway 67
D-dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation - observations from the ARISTOTLE trial 66
Cholesterol-lowering interventions and stroke: insights from a meta-analysis of randomized controlled trials 66
Tumor necrosis factor (TNF)- and Cardiovascular Diseases 66
Valuazione con RM morfometrica, AngioRM ed 1H-MRS delle modificazioni indotte dal trapianto di cellule staminali in un modello animale di ischemia muscolare 66
Monitoraggio in vivo, con Risonanza Magnetica (MR), delle modificazioni metaboliche e strutturali, indotte dal trattamento con cellule stromali derivanti dal tessuto adiposo (ADSCs), nel muscolo ischemico in un modello animale diabetico 66
Therapeutic effects of steam cell transplantation in a rat model of hind limb ischemia: an MR Imagnig, MR angiography and 1H-MR spectroscopy study. 66
Transplantation of adipose tissue mesenchymal cells conjugated with VEGF-releasing microcarriers promotes repair in murine myocardial infarction 66
The acute impact of high-dose lipid-lowering treatment on endothelial progenitor cells in patients with coronary artery disease-The REMEDY-EPC early substudy 66
Sex Implications in the Response to Anticoagulant Therapy in Atrial Fibrillation ∗ 66
Orthostatic hypotension: Epidemiology, prognosis, and treatment 66
Totale 7.816
Categoria #
all - tutte 91.784
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.784


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019947 0 0 0 0 0 0 0 0 0 0 0 947
2019/20204.949 1.836 434 16 151 390 143 590 512 107 201 544 25
2020/20212.628 485 28 507 50 224 571 32 11 88 356 102 174
2021/20221.749 24 11 10 134 238 33 36 152 145 57 233 676
2022/20235.562 582 788 260 543 517 1.175 414 368 624 73 114 104
2023/20242.282 185 61 135 40 106 761 624 104 11 35 43 177
Totale 24.556